chamaecyparis obtusa leaf extract est-il sûr pendant la grossesse ?
No harmonised CLP reproductive classification (ECHA Annex VI) and no CIR or SCCS safety assessment flagging reproductive hazard for Chamaecyparis obtusa leaf extract. Peer‑reviewed literature (PubMed) does not indicate teratogenicity or developmental toxicity; ingredient lists in CosIng and PubChem show it as a botanical extract/mixture with no GHS reproductive classification. Therefore default hazard and mechanism scores are 0; exposure is scored 1 (low but measurable dermal exposure) given it is a topical botanical extract containing small volatile/phenolic constituents that can be absorbed to some degree (CosIng, PubChem, PubMed).
Pregnancy-safe products containing chamaecyparis obtusa leaf extract









Related ingredients
Frequently asked questions
- chamaecyparis obtusa leaf extract est-il sûr pendant la grossesse ?
- No harmonised CLP reproductive classification (ECHA Annex VI) and no CIR or SCCS safety assessment flagging reproductive hazard for Chamaecyparis obtusa leaf extract. Peer‑reviewed literature (PubMed) does not indicate teratogenicity or developmental toxicity; ingredient lists in CosIng and PubChem show it as a botanical extract/mixture with no GHS reproductive classification. Therefore default hazard and mechanism scores are 0; exposure is scored 1 (low but measurable dermal exposure) given it is a topical botanical extract containing small volatile/phenolic constituents that can be absorbed to some degree (CosIng, PubChem, PubMed).
- chamaecyparis obtusa leaf extract est-il sûr pendant l'allaitement ?
- No data or regulatory classification indicating effects on lactation or transfer in milk (no ECHA harmonised H360/H361, no CIR/SCCS warnings). As for pregnancy, topical botanical extracts can have low but measurable systemic absorption, so exposure during breastfeeding is scored as low (1).
- chamaecyparis obtusa leaf extract est-il sûr pour la peau de bébé ?
- No infant‑specific reproductive or developmental toxicity data were identified (PubMed, CIR, SCCS). Because baby skin has higher per‑body‑weight exposure and an immature barrier, exposure score is increased by +1 from adult (low 1 → 2). No evidence supports raising hazard or mechanism scores for infants.
- Comment VeriMom évalue-t-il chamaecyparis obtusa leaf extract ?
- VeriMom évalue chamaecyparis obtusa leaf extract à 93/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à chamaecyparis obtusa leaf extract pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à chamaecyparis obtusa leaf extract basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.